HR 1699, the TOTAL Care Act, removes referral requirements for obstetrical and gynecological (OB/GYN) care under the TRICARE Prime health plan. It allows female TRICARE Prime beneficiaries to directly choose an OB/GYN provider as their primary care manager, eliminating the need for a prior referral from another provider. The bill establishes a 5-year pilot program to test this change, requiring the Secretary of Defense to report on enrollment shifts, cost impacts, and other outcomes after four years. This directly affects female military family members enrolled in TRICARE Prime who opt into the pilot.
HR 1657, the Humane Cosmetics Act of 2025, prohibits cosmetic companies from conducting or contracting animal testing for products sold in the U.S. beginning one year after the law takes effect. It also bans the sale or transport of cosmetics developed using such testing after that date, with limited exemptions (e.g., for foreign regulatory requirements or when no non-animal safety alternatives exist). The bill directly affects cosmetic manufacturers, retailers, and distributors by requiring them to shift to non-animal testing methods. The Food and Drug Administration (FDA) will enforce the law, including reviewing records and imposing civil penalties for violations.
The American Dream and Promise Act of 2025 would create pathways to permanent residency for certain immigrant youth who entered the U.S. as children (Dream Act component) and for individuals from countries with Temporary Protected Status or Deferred Enforced Departure (American Promise Act component). To qualify, applicants must meet continuous physical presence requirements (since January 1, 2021 for Dream Act applicants, and for 3+ years for American Promise applicants), pass background checks, and satisfy educational or employment criteria. Conditional permanent resident status would be granted initially, with the option to convert to full permanent residency after meeting additional requirements like earning a degree, serving in the military for two years, or demonstrating three years of earned income. The bill includes fee exemptions for low-income applicants, establishes a grant program to assist applicants with legal help, and creates specific procedures for background checks and appeals.
This resolution expresses the Senate's disapproval of the U.S. delegation's February 24, 2025, vote at the United Nations General Assembly against a Ukraine peace resolution (A/ES-11/L.10). It condemns the vote as the first U.S. alignment with Russia on Ukraine since 2014, criticizing the refusal to identify Russia as an aggressor or demand its withdrawal from Ukraine. The resolution has no binding effect but formally urges future UN cooperation with Ukraine and allies while reaffirming support for Ukraine's sovereignty.
HRES 166 is a non-binding House resolution expressing U.S. support for the Iranian people's desire for a democratic, secular, and nonnuclear republic. It condemns the Iranian regime's terrorism, regional proxy wars, internal suppression of ethnic and religious minorities, and human rights abuses - including executions and repression of women-led protests. The resolution calls for holding the regime accountable through sanctions, supports the Ten-Point Plan for Iran’s democratic transition, and urges protection for Iranian political refugees in Albania. It does not create new laws but affirms U.S. policy alignment with Iranian protesters' demands.
This bill creates a streamlined process for out-of-state healthcare providers to enroll in Medicaid or CHIP (Children's Health Insurance Program) in a state. It directly affects children under 21 enrolled in these programs and healthcare providers located in other states who already meet low fraud risk standards. The key provision requires states to adopt a simplified enrollment process using only basic provider information (like name and National Provider Identifier), granting eligible providers a 5-year enrollment period without repeated screening. This reduces administrative barriers for providers serving out-of-state children under 21 who qualify for Medicaid or CHIP coverage.
HR 1637, the Protect Veteran Jobs Act, allows veterans who were involuntarily dismissed without cause from federal civil service positions between January 20, 2025, and the bill’s enactment date to seek reinstatement to their former role or a qualified position. It directly affects eligible veterans dismissed during this period and requires federal agencies to report quarterly on veteran removals, including the number and reasons for each dismissal. Agencies must submit these reports to specified congressional committees until January 20, 2029, when the reporting requirement ends. The bill aims to restore employment opportunities for affected veterans while increasing transparency around federal hiring and dismissal practices.
The RAISE Act of 2025 creates a new tax credit for teachers and early childhood educators, with a base of $1,000 plus additional amounts based on school poverty rates. Teachers working in schools where more than 39% of students live in poverty can receive up to $14,000 more in tax credits, calculated based on how much a school's poverty rate exceeds 39%. The bill also increases the deduction for teachers' classroom expenses from $250 to $500 and requires schools to maintain teacher pay levels to receive certain federal funds. This directly affects public school teachers, early childhood educators, and schools serving communities with high poverty rates.
This bill amends Medicare rules to allow nurse practitioners and physician assistants to certify diabetic shoe coverage for Medicare beneficiaries with diabetes, expanding the current requirement that only physicians could provide this documentation. It directly affects Medicare patients needing specialized footwear due to diabetes and healthcare providers like NPs and PAs who would now be authorized to meet the certification requirement. The key change modifies Section 1861(s)(12) of the Social Security Act to insert "nurse practitioner, or physician assistant" in all relevant sections of the documentation rules. This update simplifies access to covered diabetic shoes by broadening which healthcare professionals can issue the necessary certification.
This resolution (SRES 93) expresses the Senate's view that the National Institutes of Health (NIH) should not face funding disruptions or operational delays that violate existing law. It specifically highlights the importance of uninterrupted NIH work on research for diseases like cancer, Alzheimer’s, diabetes, and heart disease. The resolution emphasizes that NIH scientists and researchers are essential to medical progress and public health efforts. As a symbolic resolution, it does not change funding laws or create new policies - it solely states the Senate’s position on protecting NIH operations.
This bill, S 708 (RESTORE Patent Rights Act of 2025), aims to restore a legal presumption that courts should grant permanent injunctions to stop ongoing or willful patent infringement. It directly affects patent owners, particularly individual inventors, universities, startups, and small businesses, who often struggle to obtain court orders against large companies. The key provision amends patent law to create a "rebuttable presumption" that an injunction is warranted after a final finding of infringement, shifting the burden to defendants to prove why an injunction shouldn’t be issued. This change seeks to address reduced access to injunctions in recent court decisions, which critics argue incentivizes predatory infringement against smaller patent holders.
This bill creates a new Medicaid health home program specifically for people with sickle cell disease (SCD), beginning January 1, 2026. It requires states to provide dental and vision services to SCD patients enrolled in these health homes, regardless of whether they offer such services generally to other Medicaid beneficiaries. States must also report on care quality, access, and costs for SCD patients using these specialized health homes, and the federal government must publish best practices for implementing the program by June 2026. The bill directly affects Medicaid patients diagnosed with SCD and state Medicaid programs managing these specialized care services.
